| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |